ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role? Vincenzo M. MondaFrancesca PorcellatiSandro Gentile Commentary Open access 04 August 2020 Pages: 1909 - 1914
Diabetes and Novel Coronavirus Infection: Implications for Treatment David M. WilliamsAsif NawazMarc Evans Review Open access 13 July 2020 Pages: 1915 - 1924
Are SGLT-2 Inhibitors the Future of Heart Failure Treatment? The EMPEROR-Preserved and EMPEROR-Reduced Trials David M. WilliamsMarc Evans Review Open access 24 July 2020 Pages: 1925 - 1934
Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis Nipun ShresthaShiva Raj MishraSuresh Mehata Review Open access 25 July 2020 Pages: 1935 - 1946
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Endothelial Function: A Systematic Review of Preclinical Studies Afnan S. AlshnbariSophie A. MillarIskandar Idris Review Open access 27 July 2020 Pages: 1947 - 1963
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus Sanjay KalraRakesh Sahay Review Open access 28 July 2020 Pages: 1965 - 1982
Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy Results Xue TongQun YuHongtao Yang Review Open access 05 August 2020 Pages: 1983 - 1999
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy Sandro GentileGiuseppina Guarinothe AMD-OSDI Study Group on Injection Techniques and Nefrocenter Research & Nyx Start-up Study Group Original Research Open access 18 July 2020 Pages: 2001 - 2017
Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population Yun HuYun ShenJianhua Ma Original Research Open access 21 July 2020 Pages: 2019 - 2027
Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study Yun Kyung ChoJiwoo LeeWoo Je Lee Original Research Open access 21 July 2020 Pages: 2029 - 2039
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK Mafalda RamosMichael H. CummingsMark Lamotte Original Research Open access 22 July 2020 Pages: 2041 - 2055
Establishment of a Risk Prediction Model for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes Yali ZhangRong ShiFan Hu Original Research Open access 28 July 2020 Pages: 2057 - 2073
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis Hideaki JinnouchiMakoto ImoriTakeshi Imaoka Original Research Open access 29 July 2020 Pages: 2075 - 2088
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis Junnosuke MiuraMakoto ImoriTakeshi Imaoka Original Research Open access 29 July 2020 Pages: 2089 - 2104
Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study Carlo Bruno GiordaEmanuela OrsiFranco Cavalot Original Research Open access 30 July 2020 Pages: 2105 - 2119
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis Liyun HeNa YangHuabing Zhang Original Research Open access 30 July 2020 Pages: 2121 - 2143
Role of FTO and MC4R Polymorphisms in Escalating Obesity and Their Indirect Association With Risk of T2D in Indian Population Shahbaz KhanAmit Kumar VermaKapil Dev Original Research Open access 01 August 2020 Pages: 2145 - 2157
Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study Harold W. de ValkMichael FeherGian Paolo Fadini Brief Report Open access 14 July 2020 Pages: 2159 - 2167
Does Renal Function or Heart Failure Diagnosis Affect Primary Care Prescribing for Sodium-Glucose Co-Transporter 2 Inhibitors in Type 2 Diabetes? William HintonMichael FeherSimon de Lusignan Study Protocol Open access 15 July 2020 Pages: 2169 - 2175
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach Bhawna AttriAlpesh GoyalNikhil Tandon Practical Approach Open access 18 July 2020 Pages: 2177 - 2194